Humana (NYSE:HUM) Hits New 12-Month High – What’s Next?

Humana Inc. (NYSE:HUM)’s share price reached a new 52-week high on Friday . The stock traded as high as $381.98 and last traded at $384.2350, with a volume of 114015 shares changing hands. The stock had previously closed at $376.00.

Analysts Set New Price Targets

Several research analysts have recently issued reports on HUM shares. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $425.00 price target on shares of Humana in a research note on Wednesday, June 3rd. Truist Financial increased their price objective on shares of Humana from $270.00 to $320.00 and gave the company a “hold” rating in a research note on Monday, June 1st. Zacks Research upgraded shares of Humana from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 13th. Piper Sandler restated a “neutral” rating and set a $254.00 target price (up from $182.00) on shares of Humana in a research report on Wednesday, May 13th. Finally, Wolfe Research raised shares of Humana from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $293.09.

Humana Stock Up 0.6%

The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The stock has a market cap of $45.42 billion, a price-to-earnings ratio of 40.48, a price-to-earnings-growth ratio of 2.06 and a beta of 0.76. The firm’s 50-day moving average is $299.39 and its 200 day moving average is $244.75.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same period in the previous year, the company earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts anticipate that Humana Inc. will post 9.04 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s payout ratio is currently 37.86%.

Institutional Trading of Humana

Institutional investors and hedge funds have recently bought and sold shares of the business. Montag A & Associates Inc. raised its holdings in Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the period. CoreCap Advisors LLC grew its stake in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after buying an additional 37 shares during the period. Fideuram Asset Management Ireland dac acquired a new stake in shares of Humana in the fourth quarter worth $27,000. Reflection Asset Management acquired a new stake in shares of Humana in the fourth quarter worth $29,000. Finally, Rosenberg Matthew Hamilton raised its stake in shares of Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.